Of the proposals to explain how more than 65 different rons, initiating in mid adult life and almost invariably mutations scattered throughout the SOD1 polypeptide progressing to paralysis and death over a 1-5 year time can mediate the same neurodegenerative disease, the course. While dominant inheritance accounts for only most prominent one ascribes toxicity to less tightly about 10% of the instances of disease, and SOD1 mutafolded enzymes that perform aberrant copper-mediated tions comprise fewer than 20% of those (reviewed by chemistry due to greater access of abnormal substrates Brown, 1995), the genetics provided an enormous injecto the active site copper. A slight modification is that tion of hope for dissecting the mechanism of disease, the mutants may handle the copper clumsily, frequently its neuronal selectivity, and the timing of disease onset releasing it, with the free copper catalyzing unwanted and for identifying therapeutic approaches. in either SOD1-mediated disease in mouse and humans, Where do these issues now lie? evidence from manipulating SOD1 activity levels in mice makes the peroxynitrite hypothesis unlikely to play a SOD1 Mutants Confer a Toxic Property(ies) central role. In mice that develop disease from expressThat mutation in SOD1 could be a primary cause of ing a mutant (SOD1
SOD1 mutant-mediated disease; and (4) excitotoxicity (primarily using immunocytochemistry) for whether elefrom aberrant handling of glutamate, particularly arising vated levels of the predicted nitrotyrosine are present from missplicing of a glutamate transporter mRNA.
in either SOD1-mediated disease in mouse and humans, Where do these issues now lie? evidence from manipulating SOD1 activity levels in mice makes the peroxynitrite hypothesis unlikely to play a SOD1 Mutants Confer a Toxic Property(ies) central role. In mice that develop disease from expressThat mutation in SOD1 could be a primary cause of ing a mutant (SOD1
G85R
) that confers only a ‫%01ف‬ inselective motor neuron degeneration was initially anycrease in SOD1 activity over the endogenous, wild-type thing but obvious. Ubiquitously expressed, the known SOD1, neither elimination nor elevation (by ‫-6ف‬fold) of activity of this 153-amino-acid, cytoplasmic homodimer wild-type SOD1 affected disease onset, progression, or is to convert superoxide, produced primarily by errors pathology (Bruijn et al., 1998). The insensitivity of toxicity of oxidative phosphorylation in mitochondria, to water to SOD1 activity levels is inconsistent with damage arisand hydrogen peroxide. Catalysis is mediated in two ing from superoxide or any spontaneous reaction prodasymmetric steps by an essential copper atom, which uct of it (such as Ϫ ONOO), since absence of the wild-type is alternately reduced and then oxidized by superoxide protein would accelerate toxicity by raising superoxide ( Figure 1A ). While early measurements of SOD1 activity levels and/or forcing all catalysis through the mutant, in patient blood suggested loss of enzymatic activity while elevating it would do the opposite. This was clearly to be central to the mechanism of disease, an initial not the case, at least for the SOD1 G85R mutant. transgenic mouse expressing familial ALS-linked mu-A second proposed aberrant substrate is hydrogen tant SOD1 G93A (i.e., glycine substituted to alanine at posiperoxide, the normal end product released from the tion 93) developed progressive motor neuron disease oxidized form of the enzyme (Cu 2ϩ -SOD1). Use of peroxdespite markedly elevated SOD1 activity levels (Gurney ide by the reduced Cu ϩ -SOD1 form, on the other hand, et al., 1994). This has been extended by three additional may produce the extraordinarily reactive hydroxyl radical ( Figure 1C) , thereby leading to a cascade of peroxidation. A 2-to 4-fold increased utilization in vitro of Whatever the case, the seminal discovery that copper acquisition by SOD1 in yeast requires CCS, a specific copper chaperone for SOD1 (Culotta et al., 1997) , has allowed design of a test in a single experiment of all possible, copper-mediated toxicities. Since both the human wild-type and mutant SOD1s apparently load copper in vivo through the action of a mammalian CCS (Corson et al., 1998), production of SOD1 mutantexpressing mice that are also deleted for the single mammalian CCS will directly test the requirement for copper (and any catalyzed oxidative damage) in SOD1 mutant toxicity. This experiment, which has the power to disprove copper-mediated oxidative mechanisms should toxicity prove insensitive to copper loading, is well underway in at least one group (P. Wong, personal communication), with a clear answer anticipated by early next year. This commonality has selves capable of provoking disease with high penefueled a long-standing debate over whether these agtrance, the collective evidence now strongly hints that gregates are key to the pathogenesis, harmless byprodvariants in neurofilaments are, at the least, important ucts, or potentially beneficial through sequestration of risk factors for apparently sporadic disease. aberrant products. The likelihood that aggregates might be contributors to ALS was significantly boosted by the finding that all examples of SOD1 mutant-mediated Axonal Strangulation from Chronic Deficits in Transport disease in mice develop prominent, cytoplasmic, intracellular inclusions in motor neurons, and in some cases Because biosynthesis of macromolecules is almost completely restricted to neuronal cell bodies, axonal within the astrocytes surrounding them as well. These aggregates develop by the onset of clinical disease, in transport is especially crucial to the long, large caliber motor axons. The known neurofilament-dependent slowsome cases (e.g., SOD1 G85R mice) representing the first pathologic sign of disease, and later increase markedly ing of axonal transport, combined with the prominent misaccumulation of neurofilaments in ALS, suggested in abundance during disease progression (Bruijn et al. , 1997) . that an important aspect of toxicity may arise from damage to transport. Chronic deficits in transport of selecAs to their composition, the striking feature is that aggregates are intensely immunoreactive with antibodtive cargoes of slow transport have now been seen as very early features, initiating up to 5 months prior to ies to SOD1, a feature common not only to all instances of disease in mice but also to several SOD1-mediated clinical disease onset in mice expressing SOD1 G85R and SOD1 G37R mutants (Williamson and Cleveland, 1999 which most frequently reveal intense, concentrated spinal motor neurons, glutamate recovery is the job of astrocytes, which synthesize the major spinal cord SOD1 immunoreactivity throughout the inclusion or, less frequently, only at the periphery of it. The second class transporter EAAT2 (previously known as GLT-1). For ALS, early evidence for involvement of glutamate came includes more diffusely staining perikaryal deposits. Mating SOD1 mutant mice to mice deleted at the endogfrom the demonstration of selective, local loss of EAAT2: affected tissue regions from about two-thirds of spoenous SOD1 alleles or to mice expressing wild-type SOD1 to six times the normal level has shown that the radic ALS patients were found to have up to 95% losses in EAAT2 levels and activity (Rothstein et al., 1995). timing, abundance, and staining intensities of the aggregates are independent of wild-type SOD1. While immuMechanistically, this does not arise from mutation but apparently from selective errors in splicing of the EAAT2 nocytochemistry is among the world's worst quantitative tools, it seems safe to conclude that mutant SOD1 mRNA. This has been reported within affected, but not unaffected, regions of the two-thirds of sporadic pais one primary component of these aggregates.
Neurofilaments as Contributors and Risk Factors in ALS
Aggregation, or at least misfolded subunits, is thus tients that show diminished glutamate transport activity (Lin et al., 1998). In fact, evidence for many aberrantly apparently a characteristic of the SOD1 mutants. This has been reproduced selectively in motor neurons by spliced RNA species was reported, with two prominent products either with exon 9 skipped or intron 7 retained. microinjection of genes encoding mutant but not wild type SOD1. This approach has yielded what may be the Both make nonfunctional truncated products, and the latter dominantly inhibits normal EAAT2-mediated transbest in vitro model of disease, including aggregates selectively in motor (but not sensory or hippocampal) port. These powerful findings strongly support a role for neurons (Durham et al., 1997) 
